Evidence map›Paper›PMID 31861527›Full record

SynthesisMarine drugs2019

Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Alejandro M S Mayer, Aimee J Guerrero, Abimael D Rodríguez, Orazio Taglialatela-Scafati, Fumiaki Nakamura, Nobuhiro Fusetani

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Promising antiparasitic agents from marine sponges.Saudi journal of biological sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Alejandro M S MayerDepartment of Pharmacology, College of Graduate Studies, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA.
Aimee J GuerreroDepartment of Pharmacology, College of Graduate Studies, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA.
Abimael D RodríguezMolecular Sciences Research Center, University of Puerto Rico, 1390 Ponce de León Avenue, San Juan, PR 00926, USA.
Orazio Taglialatela-ScafatiDepartment of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, I-80131 Napoli, Italy.ORCID 0000-0001-8010-0180
Fumiaki NakamuraDepartment of Chemistry and Biochemistry, Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan.
Nobuhiro FusetaniFisheries and Oceans Hakodate, Hakodate 041-8611, Japan.
Midwestern University · USHakodate University · JPUniversity of Naples Federico II · ITUniversity of Puerto Rico System · PRWaseda University · JP

Funding

New Leads Against Cancer and Infectious Diseases from Puerto Rican Reef SpeciesSC1GM086271 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI RODRIGUEZ, ABIMAEL D · 2010 to 2013
$1.2M
NIGMS NIH HHS SC1 GM086271NIH HHS 1SC1GM086271-01A1Regione Campania-POR Campania FESR 2014/2020 "Combattere la resistenza tumorale: piattaforma integrata multidisciplinare per un approccio tecnologico innovativo alle oncoterapie-Campania Oncoterapie Project N. B61G18000470007
6 · The paper itself

Abstract

The systematic review of the marine pharmacology literature from 2014 to 2015 was completed in a manner consistent with the 1998-2013 reviews of this series. Research in marine pharmacology during 2014-2015, which was reported by investigators in 43 countries, described novel findings on the preclinical pharmacology of 301 marine compounds. These observations included antibacterial, antifungal, antiprotozoal, antituberculosis, antiviral, and anthelmintic pharmacological activities for 133 marine natural products, 85 marine compounds with antidiabetic, and anti-inflammatory activities, as well as those that affected the immune and nervous system, and 83 marine compounds that displayed miscellaneous mechanisms of action, and may probably contribute to novel pharmacological classes upon further research. Thus, in 2014-2015, the

Indexed as

Oceans and SeasAnimalsAnthelminticsAnticoagulantsAntifungal AgentsAnti-Inflammatory AgentsAntiprotozoal AgentsAntitubercular AgentsAntiviral AgentsBiological ProductsHumansHypoglycemic AgentsImmune SystemNervous SystemAnthelminticsAnticoagulantsAntifungal AgentsAnti-Inflammatory AgentsAntiprotozoal AgentsAntitubercular AgentsAntiviral AgentsBiological ProductsHypoglycemic Agentschemicaldrugmarinemetabolitenatural productpharmaceuticalpharmacologypipelinereviewtoxicology

Identifiers

PMID31861527
PMCPMC7024264
OpenAlexW2994693763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.